Medikabazaar, a medical supply chain platform, is seeking to raise $50 million after overcoming a significant governance scandal. The company aims to restore investor confidence by targeting ₹3,000 crore revenue in FY27 and reporting a positive Ebitda of ₹5 crore. Founded in 2015, Medikabazaar connects hospitals with medical supplies through a B2B platform. Following a whistleblower complaint in 2023 that exposed financial irregularities, the company has undergone a board overhaul and is now positioning itself for a strategic comeback. Existing investors like British International Investment and HealthQuad are expected to participate in this funding round, signaling potential renewed trust in the company's leadership and growth strategy.
Post from MarketNews_en
Log in to interact with content.